Substance / Medication

Lithium citrate

Overview

Active Ingredient
lithium citrate
RxNorm CUI
52105

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

2 trials linked to this intervention

2
Total Trials
2
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Undetectable serum lithium concentrations after coadministration of liquid lithium citrate and apple juice: A case report.
Awan Sundus, Abelleira Audrey, Khehra Loveleen et al. · Ment Health Clin · 2021
PMID: 33505823Case ReportFull text (PMC)
Lithium citrate for Canavan disease.
Janson Christopher G, Assadi Mitra, Francis Jeremy et al. · Pediatr Neurol · 2005
PMID: 16194720Case Report
Phase diagrams of PEG+ lithium citrate + water ATPSs, and the partitioning of salbutamol at T = 298.15 K.
Nemati-Kande Ebrahim, Azizi Zolfa, Mokarizadeh Marziyeh · Sci Rep · 2023
PMID: 36658224OtherFull text (PMC)
Lithium Citrate Triggered Macroscopic Superlubricity with Near-Zero Wear on an Amorphous Carbon Film.
Sun Shouyi, Yi Shuang, Li Jinjin et al. · ACS Appl Mater Interfaces · 2023
PMID: 37018161Other
Terahertz spectroscopy detection of lithium citrate tetrahydrate and its dehydration kinetics.
Gao Jiankui, Li Yijie, Liu Jingbo et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2022
PMID: 34649122Other
Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.
Brand Toni M, Wheeler Deric L · Cancer Biol Ther · 2011
PMID: 21228636Other
Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.
Assadi Mitra, Janson Christopher, Wang Dah-Jyuu et al. · Eur J Paediatr Neurol · 2010
PMID: 20034825Other
The role of lithium carbonate and lithium citrate in regulating urinary citrate level and preventing nephrolithiasis.
Zhang Xiaobo, Aggarwal Piyush, Li Xiaoming et al. · Int J Biomed Sci · 2009
PMID: 23675140OtherFull text (PMC)
Visual compatibility of risperidone solution and lithium citrate syrup.
Park Susie H, Gill Mark A, Dopheide Julie A · Am J Health Syst Pharm · 2003
PMID: 12659069Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lithium citrate (substance)
SNOMED CT
387098001
UMLS CUI
C0125997
RxNorm CUI
52105

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

4
Conditions
5
Biomarkers
2
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.